跳至主要内容
临床试验/IRCT20221119056535N1
IRCT20221119056535N1招募中3 期

Investigating the effect of Remifentanil and Labtalol, in combination with Propofol, on hemodynamic changes in nasal endoscopy

Qazvin University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 60 years(—)
性别
All

入选标准

  • Willingness to participate in research with informed consent after giving necessary and sufficient explanations about the study
  • The age of the person should be between 15 and 60 years
  • There is no history of surgery and it is the patient's first surgery
  • Not having a chronic mental or physical illness (schizophrenia, diabetes, etc.)
  • Not having vision and hearing problems and other disabilities
  • No allergy to Remifentanil, Profol and Labtalol
  • Absence of pregnancy, breastfeeding and abortion less than 3 months

排除标准

  • Heart diseases and HTN
  • Liver diseases (cirrhosis, hepatitis, etc.)

研究者

相似试验